Literature DB >> 6128298

H2-receptor antagonists and hepatic drug disposition.

G W Mihaly, R A Smallwood, J D Anderson, D B Jones, L K Webster, F J Vajda.   

Abstract

The effect of four H2-receptor antagonists (cimetidine, burimamide, oxmetidine, and ranitidine) on antipyrine elimination was studied in the isolated perfused rat liver. The first three drugs are substituted imidazoles, whereas ranitidine contains a furanyl nucleus. Isolated livers were perfused using a 100-ml, recycling, constant flow circuit for 4 hr. Antipyrine elimination was studied with or without an H2-receptor antagonist present. In all experiments, antipyrine concentrations declined monoexponentially. In control experiments (no other drug present), antipyrine clearance was 32.5 +/- 0.9 ml per hr. This was greatly reduced in the presence of cimetidine (clearance = 10.1 +/- 0.8 and 5.8 +/- 1.5 ml per hr after 1 and 5 mg doses, p less than 0.01) and burimamide (4.5 +/- 0.6 and 3.0 +/- 1.7 ml per hr, p less than 0.001). By contrast, neither oxmetidine nor ranitidine significantly altered antipyrine pharmacokinetics. These results indicate that the inhibitory effect on hepatic mixed-function oxidases is rapid in onset, independent of H2-receptor antagonist activity, and is not an inevitable consequence of the presence of an imidazole nucleus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128298     DOI: 10.1002/hep.1840020615

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  Pharmacokinetic studies of cimetidine and ranitidine before and after treatment in peptic ulcer patients.

Authors:  G W Mihaly; D B Jones; J A Anderson; R A Smallwood; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

3.  Ranitidine does not alter pethidine disposition in man.

Authors:  D R Guay; R C Meatherall; J L Chalmers; G R Grahame; R J Hudson
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

4.  Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.

Authors:  L K Webster; A G Ellis; J F Bishop
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Primary and secondary metabolism of pentamidine by rats.

Authors:  B J Berger; N A Naiman; J E Hall; J Peggins; T G Brewer; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 6.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.